Azetidin-3-ylmethanamine dihydrochloride is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug compounds. Its structure is valuable in the creation of beta-lactam antibiotics and other biologically active molecules. The compound is often employed as a key intermediate in the production of inhibitors targeting enzymes or receptors involved in various diseases. Additionally, it finds application in the study of central nervous system disorders due to its potential interaction with neurotransmitter systems. Its role in medicinal chemistry highlights its importance in advancing therapeutic innovations.